project id: TCGA-PRAD; case submitter id: TCGA-EJ-5524; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 57; days to birth: -20854; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 20854; ajcc clinical m: M0; ajcc clinical t: T2b; ajcc pathologic n: N0; ajcc pathologic t: T3a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1882.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; weight: 35.0; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.7; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-EJ-5524-01A-01; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0;